UTAH MEDICAL PRODUCTS INC
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $38.5M | $40.9M | $50.2M | $52.3M | $49.1M | $42.2M | $46.9M |
| Cost of Revenue | — | $16.5M | $16.8M | $20.2M | $20.1M | $18.1M | $16.6M | $17.4M |
| Gross Profit | — | $22.0M | $24.1M | $30.0M | $32.2M | $30.9M | $25.5M | $29.5M |
| Gross Margin | — | 57.1% | 59.0% | 59.8% | 61.6% | 63.0% | 60.6% | 62.8% |
| Operating Expenses | ||||||||
| Research & Development | — | $668.0K | $813.0K | $560.0K | $493.0K | $526.0K | $486.0K | $483.0K |
| SG&A Expense | — | $7.9M | $7.8M | $11.0M | $10.4M | $10.1M | $9.8M | $9.6M |
| Operating Income | — | $11.4M | $13.6M | $16.8M | $19.8M | $18.9M | $13.7M | $17.6M |
| Operating Margin | — | 29.6% | 33.2% | 33.4% | 37.9% | 38.5% | 32.5% | 37.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $14.1M | $16.8M | $20.1M | $20.7M | $19.1M | $13.8M | $17.9M |
| Income Tax Expense | — | $2.8M | $2.9M | $3.5M | $4.2M | $4.3M | $3.0M | $3.2M |
| Net Income | — | $11.3M | $13.9M | $16.6M | $16.5M | $14.8M | $10.8M | $14.7M |
| Net Margin | — | 29.3% | 33.9% | 33.1% | 31.5% | 30.1% | 25.6% | 31.4% |
| EPS (Basic) | — | $3.48 | $3.96 | $4.58 | $4.53 | $4.05 | $2.95 | $3.96 |
| EPS (Diluted) | — | $3.48 | $3.96 | $4.57 | $4.52 | $4.04 | $2.94 | $3.94 |
| Shares Outstanding (Basic) | 3.2M | 3.2M | 3.5M | 3.6M | 3.6M | 3.6M | 3.7M | 3.7M |
| Shares Outstanding (Diluted) | 3.2M | 3.2M | 3.5M | 3.6M | 3.6M | 3.7M | 3.7M | 3.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |